miR-31 functions as an oncogene in cervical cancer

Archives of Gynecology and Obstetrics

Volumn 292, Issue 5, 2015, Pages 1083-1089

  Zheng, Wenjing ^a   Liu, Zhen ^a   Zhang, Wei ^a   Hu, Xiaoxia ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

Author keywords

Biological function; Cervical cancer; HPV; miR 31

Indexed keywords

MICRORNA 31; PROTEIN E6; PROTEIN E7; SMALL INTERFERING RNA; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; MICRORNA; MIRN31 MICRORNA, HUMAN; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; C33A CELL LINE; CANCER CELL LINE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEALTH STATUS; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 16 E6; HUMAN PAPILLOMAVIRUS TYPE 16 E7; HUMAN TISSUE; LYMPH NODE METASTASIS; NONHUMAN; ONCOGENE; ONCOGENE MIR 31; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIHA CELL LINE; TUMOR INVASION; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VERRUCA VULGARIS; AGED; CASE CONTROL STUDY; CELL TRANSFORMATION; DRUG EFFECTS; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

AGED; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HELA CELLS; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84942984952     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3713-2     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
2. Shi TY, Chen XJ, Zhu ML, Wang MY, He J, Yu KD, Shao ZM, Sun MH, Zhou XY, Cheng X, Wu X, Wei Q (2013) A pri-miR-218 variant and risk of cervical carcinoma in Chinese women. BMC Cancer 13:19
3. Zhang J, Li S, Yan Q, Chen X, Yang Y, Liu X, Wan X (2013) Interferon-beta induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells. PLoS One 8:e81366
4. Wilting SM, Snijders PJ, Verlaat W, Jaspers A, van de Wiel MA, van Wieringen WN, Meijer GA, Kenter GG, Yi Y, le Sage C, Agami R, Meijer CJ, Steenbergen RD (2013) Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 32:106–116
5. Korner C, Keklikoglou I, Bender C, Worner A, Munstermann E, Wiemann S (2013) MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKC epsilon). J Biol Chem 288:8750–8761
6. Wang N, Zhou Y, Zheng L, Li H (2014) MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. Gynecol Oncol 134:129–137
7. Rao Q, Shen Q, Zhou H, Peng Y, Li J, Lin Z (2012) Aberrant microRNA expression in human cervical carcinomas. Med Oncol 29:1242–1248
8. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3:e2557
9. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136:586–591
10. Xu RS, Wu XD, Zhang SQ, Li CF, Yang L, Li DD, Zhang BG, Zhang Y, Jin JP, Zhang B (2013) The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer. Int J Oncol 42:676–682
11. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak M, Freemantle SJ, Kauppinen S, Dmitrovsky E (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120:1298–1309
12. Wang S, Li Q, Wang K, Dai Y, Yang J, Xue S, Han F, Zhang Q, Liu J, Wu W (2013) Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer. Clin Transl Oncol 15:849–854
13. Cheung TH, Man KN, Yu MY, Yim SF, Siu NS, Lo KW, Doran G, Wong RR, Wang VW, Smith DI, Worley MJ, Berkowitz RS, Chung TK, Wong YF (2012) Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 11:2876–2884
14. Rahma OE, Herrin VE, Ibrahim RA, Toubaji A, Bernstein S, Dakheel O, Steinberg SM, Abu ER, Mkrtichyan M, Berzofsky JA, Khleif SN (2014) Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer. J Transl Med 12:353
15. Nambaru L, Meenakumari B, Swaminathan R, Rajkumar T (2009) Prognostic significance of HPV physical status and integration sites in cervical cancer. Asian Pac J Cancer Prev 10:355–360
16. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27:2575–2582
17. Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J (2006) Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12:2014–2024
18. Melar-New M, Laimins LA (2010) Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 84:5212–5221
19. Li B, Hu Y, Ye F, Li Y, Lv W, Xie X (2010) Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer 20:597–604
20. Au YC, Tsang TY, Yau PL, Kwok TT (2011) Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene 30:2401–2410
21. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T, Vassella E (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69:5553–5559
22. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D’Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14:1271–1277
23. Zhao S, Yao DS, Chen JY, Ding N (2013) Aberrant expression of miR-20a and miR-203 in cervical cancer. Asian Pac J Cancer Prev 14:2289–2293
24. Chen J, Yao D, Zhao S, He C, Ding N, Li L, Long F (2014) MiR-1246 promotes SiHa cervical cancer cell proliferation, invasion, and migration through suppression of its target gene thrombospondin 2. Arch Gynecol Obstet 290:725–732
25. Li JH, Xiao X, Zhang YN, Wang YM, Feng LM, Wu YM, Zhang YX (2011) MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells. Gynecol Oncol 120:145–151
26. Yao T, Lin Z (2012) MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochim Biophys Acta 1822:248–260
27. Hu X, Schwarz JK, Lewis JJ, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X (2010) A microRNA expression signature for cervical cancer prognosis. Cancer Res 70:1441–1448
28. Zhang T, Wang Q, Zhao D, Cui Y, Cao B, Guo L, Lu SH (2011) The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond) 121:437–447
29. Wang A, Landen NX, Meisgen F, Lohcharoenkal W, Stahle M, Sonkoly E, Pivarcsi A (2014) MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells. PLoS One 9:e103206
30. Hu C, Huang F, Deng G, Nie W, Huang W, Zeng X (2013) miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1. Exp Ther Med 6:1265–1270
31. Lei SL, Zhao H, Yao HL, Chen Y, Lei ZD, Liu KJ, Yang Q (2014) Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells. Oncol Lett 8:1768–1774
32. Aprelikova O, Yu X, Palla J, Wei BR, John S, Yi M, Stephens R, Simpson RM, Risinger JI, Jazaeri A, Niederhuber J (2010) The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 9:4387–4398
33. Cottonham CL, Kaneko S, Xu L (2010) miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem 285:35293–35302